These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27142176)

  • 21. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives.
    Natale M; Mirone G; Rotondo M; Moraci A
    Clin Neurol Neurosurg; 2012 May; 114(4):321-5. PubMed ID: 22104692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathecal baclofen improves psychiatric symptoms in spasticity patients.
    Margetis K; Papageorgiou G; Gatzonis S; Politis K; Siatouni A; Sakas D
    J Clin Psychopharmacol; 2014 Jun; 34(3):374-9. PubMed ID: 24743715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spasticity and intrathecal baclofen.
    Furr-Stimming E; Boyle AM; Schiess MC
    Semin Neurol; 2014 Nov; 34(5):591-6. PubMed ID: 25520030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
    Bensmail D; Quera Salva MA; Roche N; Benyahia S; Bohic M; Denys P; Bussel B; Lofaso F
    Neurology; 2006 Oct; 67(8):1432-6. PubMed ID: 17060570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience.
    Sammaraiee Y; Yardley M; Keenan L; Buchanan K; Stevenson V; Farrell R
    Mult Scler Relat Disord; 2019 Jan; 27():95-100. PubMed ID: 30366276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of intrathecal baclofen therapy on spasticity in patients with brain injury].
    Dénes Z; Klauber A; Both B; Lóránd E
    Ideggyogy Sz; 2012 Jul; 65(7-8):243-8; discussion 248. PubMed ID: 23074844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of intrathecal baclofen delivery in the management of severe spasticity in upper motor neuron syndrome.
    Rietman JS; Geertzen JH
    Acta Neurochir Suppl; 2007; 97(Pt 1):205-11. PubMed ID: 17691378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury.
    Horn TS; Yablon SA; Stokic DS
    Arch Phys Med Rehabil; 2005 Jun; 86(6):1127-33. PubMed ID: 15954050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A.
    Biering-Soerensen B; Stevenson V; Bensmail D; Grabljevec K; Martínez Moreno M; Pucks-Faes E; Wissel J; Zampolini M
    J Rehabil Med; 2022 Jan; 54():jrm00241. PubMed ID: 34608495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraventricular baclofen as an alternative to intrathecal baclofen for intractable spasticity or dystonia: outcomes and technical considerations.
    Turner M; Nguyen HS; Cohen-Gadol AA
    J Neurosurg Pediatr; 2012 Oct; 10(4):315-9. PubMed ID: 22861196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal baclofen therapy: ten steps toward best practice.
    Ridley B; Rawlins PK
    J Neurosci Nurs; 2006 Apr; 38(2):72-82. PubMed ID: 16681287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathecal baclofen therapy in paediatrics: a study protocol for an Australian multicentre, 10-year prospective audit.
    Stewart K; Hutana G; Kentish M
    BMJ Open; 2017 Jun; 7(6):e015863. PubMed ID: 28637739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weight changes in children receiving intrathecal baclofen for the treatment of spasticity.
    Pritula SL; Fox MA; Ayyangar R
    J Pediatr Rehabil Med; 2012; 5(3):197-201. PubMed ID: 23023252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quality of life in cerebral palsy children treated with intrathecal baclofen pump implantation in parents' opinion].
    Borowski A; Pruszczyński B; Miller F; Synder M
    Chir Narzadow Ruchu Ortop Pol; 2010; 75(5):318-22. PubMed ID: 21853903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The underutilization of intrathecal baclofen in poststroke spasticity.
    Dvorak EM; Ketchum NC; McGuire JR
    Top Stroke Rehabil; 2011; 18(3):195-202. PubMed ID: 21642057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged anti-spasticity effects of bolus intrathecal baclofen.
    Baguley IJ; Bailey KM; Slewa-Younan S
    Brain Inj; 2005 Jul; 19(7):545-8. PubMed ID: 16134742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a cost-effectiveness analysis.
    Hoving MA; Evers SM; Ament AJ; van Raak EP; Vles JS;
    Dev Med Child Neurol; 2008 Jun; 50(6):450-5. PubMed ID: 18422682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrathecal baclofen in multiple sclerosis: too little, too late?
    Erwin A; Gudesblatt M; Bethoux F; Bennett SE; Koelbel S; Plunkett R; Sadiq S; Stevenson VL; Thomas AM; Tornatore C; Zaffaroni M; Hughes M
    Mult Scler; 2011 May; 17(5):623-9. PubMed ID: 21282321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up.
    Rekand T; Grønning M
    J Rehabil Med; 2011 May; 43(6):511-4. PubMed ID: 21533331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of intrathecal baclofen (ITB) therapy in spacticity.
    Ucar T; Kazan S; Turgut U; Samanci NK
    Turk Neurosurg; 2011 Jan; 21(1):59-65. PubMed ID: 21294093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.